Business · 23/01/2017Updated: 10/17/2026 · 1 min read
FDA Proposes Standard to Limit N-Nitrosonornicotine in Smokeless Tobacco Products
Summary
The Food and Drug Administration (FDA) is proposing a standard to limit N-nitrosonornicotine (NNN) in finished smokeless tobacco products, a move aimed at reducing the elevated cancer risks associated with smokeless tobacco use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →